Drug makers to perform favorable sales and profits in 1/2 of 2005.

In contrast to the listed pharmaceutical companies of the fiscal year ended at Dec. 31, the business performance of the listed pharmaceutical companies with a fiscal year ended at March 31 during the first half of the fiscal year of 2005 showed remarkable improvements with sales and profits, attracting more interests in which most of those companies put more weight in their business to the non-...